P. Jones (London, United Kingdom), M. Partridge (London, United Kingdom)
Tobacco exposure and health-related quality of life in COPD C. Santiveri, A. Marín Arguedas, F. X. Díaz Carrasco, M. Espinalt, E. Miguel (Barcelona, Spain)
| |
Psychometric validation of the Visual Simplified Respiratory Questionnaire (VSRQ) in France for chronic obstructive pulmonary disease (COPD) A. B. Tonnel, T. Perez, J. M. Grosbois, V. Bosch, M. L. Bravo, M. Brun (Lille, Lyon, Reims, France)
| |
The quality of life (QL) and clinical-functional parameters at COPD I. N. Trofimenko, B. A. Chernyak (Irkutsk, Russian Federation)
| |
Linguistic validation of the Clinical COPD Questionnaire (CCQ) for use in international studies I. Mear, A. C. Moerk, T. van der Molen, M. Lindemann (Lyon, France; Lund, Sweden; Groningen, Netherlands; Konstanz, Germany)
| |
Severity of disease and health-related quality of life in patients with chronic obstructive pulmonary disease I. V. Cekerevac, Z. M. Lazic, L. A. Novkovic, V. M. Bosnjak- Petrovic, M. D. Vukcevic (Kragujevac, Beograd, Serbia And Montenegro)
| |
Fatigue and quality of life among patients with COPD K. Theander, P. Jacobsson, O. Torstensson, M. Unosson (Linkoping, Oskarshamn, Sweden)
| |
Measuring the impact of COPD on patients‘ lives in an international study I. Mear, G. Gyuatt, F. Jost, L. Zamora, H. J. Schunemann (Lyon, France; Hamilton, Canada; Basel, Switzerland; Nutley, Buffalo, United States Of America)
| |
Gender difference noted for patients with chronic obstructive pulmonary disease (COPD) by a lung information needs questionnaire (LINQ) R. Wakabayashi, K. Kida, K. Yamaguchi, K. Segawa, E. Handa, R. Jones, M. Hyland (Tokyo, Japan; Plymouth, United Kingdom)
| |
Psychometric validation of an electronic diary to measure symptoms of COPD D. Clayson, A. Johnson, C. Gilbert, M. Jackson, A. Hareendran, C. Compton, H. Schunemann (Oxford, Kent, United Kingdom; New York, United States Of America)
| |
Epidemiological study to assess the quality of life and health care resource utilization by patients with mild COPD (EPIDEPOC) M. Garcia, P. Carrasco, R. Jimenez, A. Martin, E. Gobartt, A. Gil (Madrid, Barcelona, Spain)
| |
Prevalence of anxiety and depression in COPD: are females at higher risk? M. Verga, F. Di Marco, M. Reggente, F. Casanova, P. Santus, B. Boveri, S. Pizzolato, S. Centanni (Milan, Italy)
| |
Diagnostic sensitivity of a symptom-based questionnaire, the Canadian Lung Health Test (CLHT), in subjects at risk for COPD R. Hodder, L. Calcutt (Ottawa, Canada)
| |
Ten questions about metered dose inhalers: the quality of patient‘s knowledge about aerosol therapy V. V. Petrovic, S. V. Raljevic, B. Stanic (Belgrade, Serbia And Montenegro)
| |
The effect of different bronchodilator drugs on pulmonary function tests, exercise capacity and quality of life in patients with COPD S. Kiris, A. Mirici, M. Akgun, M. Meral, M. Gorguner (Erzurum, Turkey)
| |
Living with COPD: patients‘ unmet needs J. Cleland, S. Hall (Aberdeen, United Kingdom)
| |
Health status measurement in COPD patients. Correlations with dyspnea and physiologic outcomes M. V. Lopez Varela, M. Mamchur, T. Anido, E. Pacheco, F. Gimenez, K. Fagundez, C. Silva (Montevideo, Uruguay)
| |
Nutritional assessment, pulmonary function, exercise capacity and quality of life in COPD patients J. J. Garrido, L. Mateos, M. J. Antona, J. A. Gutierrez, G. Garcia de Vinuesa, I. Rodriguez, P. Cordero, F. L. Marquez, F. J. Fuentes (Badajoz, Spain)
| |
Correlation between life quality parameters and anthropometric data in the patients with chronic obstructive lung diseases M. Salaeva (Tashkent, Uzbekistan)
| |
Patients with COPD have low level of knowledge about their disease B. Alcazar, G. Jimenez, C. Martin, B. Hortal, M. M Ceres, I. Casado (Granada, Spain)
| |
Degree of knowledge of COPD patients about their own disease and effect of an informative leaflet J. A. Lloret, Y. Chicon, N. Rodriguez, E. Arellano, S. Calvo, M. Miravitlles, J. Ruiz, J. Morera, A. Rosell (Barcelona, St. Adrià del Besós, Spain)
| |